Human SSTR2 Stable Cell Line-CHO-K1

Human SSTR2 encodes a Gi/o-coupled somatostatin receptor widely studied in neuroendocrine tissues and tumors. Its activation by somatostatin and related peptide analogs initiates inhibition of adenylyl cyclase together with effects on ion channels, phosphatases, secretion, and proliferation, making receptor abundance and cellular context important determinants of experimental response. This product is a stable CHO-K1 cell line engineered to maintain elevated expression of human SSTR2. This cell line is engineered to stably overexpress Human SSTR2 in CHO-K1 cells. CHO-K1 cells offer robust growth, a comparatively low endogenous background for many human receptors, and a long history of use in pharmacology and screening. Stable integration reduces the experiment-to-experiment variability associated with transient transfection and supports repeated use across assay campaigns.

Functionally, the line is intended to provide consistent access to human SSTR2-dependent biology. It is particularly suitable for agonist and antagonist profiling, ligand-binding assays, receptor internalization studies, potency ranking of somatostatin analogs, and research related to endocrine signaling, neuroendocrine tumors, and receptor-targeted imaging or therapy. As a defined receptor-overexpression model, the cell line complements primary cells and tissue-derived systems by isolating target-dependent signaling from the complexity of mixed receptor populations. Its stable phenotype supports comparative pharmacology across compound series, biologic formats, and repeated screening campaigns, while preserving the same host-cell background for mechanistic interpretation. The model also provides a consistent framework for linking receptor occupancy to proximal signaling, receptor trafficking, and downstream cellular responses relevant to target validation and drug discovery. Receptor-focused datasets generated with this line can clarify ligand potency, efficacy, selectivity, desensitization, and internalization within a single cellular context. The platform is also relevant to comparative studies of small molecules, peptides, antibodies, and other biologic modulators directed at the same signaling axis.